HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revco/Big B confidentiality agreement includes stay on poison pill suit.

This article was originally published in The Rose Sheet

Executive Summary

BIG B PUTS POISON PILL ON HOLD, ENTERS REVCO CONFIDENTIALITY AGREEMENT to provide Revco with confidential information pertaining to its proposed acquisition of Big B, Twinsburg, Ohio-based Revco announced Oct. 4. The agreement includes a stay on the litigation regarding Big B's "poison pill" shareholder rights plan that would activate when an acquiring company attempts to purchase 10% or more of Big B "without prior approval of the Big B board of directors."

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003311

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel